Report Detail
Global Bispecific and Trispecific Antibody Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4422812 |
- 13 April, 2022 |
- Global |
- 111 Pages |
- QYResearch |
- Medical Industry
Summary:
Market Insights
The research report studies the Bispecific and Trispecific Antibody market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, the global Bispecific and Trispecific Antibody market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.
The global main companies of Bispecific and Trispecific Antibody include AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics and Numab, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
The North America Bispecific and Trispecific Antibody market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Bispecific and Trispecific Antibody landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Bispecific Antibody accounting for % of the Bispecific and Trispecific Antibody global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancer segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Bispecific Antibody
Trispecific Antibody
Segment by Application
Cancer
Haemophilia
Others
Regional Scope
This segment of the report offers a thorough regional study of the global Bispecific and Trispecific Antibody market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
AbbVie
Affimed
Biotheus
Biontech
Genmab
GT Biopharma
Harpoon Therapeutics
MacroGenics
Numab
Sanofi
Sichuan Baili Pharmaceuticals
Roche
Amgen
Pfizer
Johnson & Johnson
AstraZeneca
Frequently Asked Questions
Which application segment captured the leading share in the Bispecific and Trispecific Antibody market?
How fragmented is the Bispecific and Trispecific Antibody market?
Which are the key growth drivers in the Bispecific and Trispecific Antibody market?
Which are the top strategies undertaken by the Bispecific and Trispecific Antibody market players?
Which technological trends are likely to affect the Bispecific and Trispecific Antibody market?
What is the expected Bispecific and Trispecific Antibody market size by 2028?
Which companies are dominating the Bispecific and Trispecific Antibody market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Bispecific and Trispecific Antibody market growth?
Which are the emerging companies in the Bispecific and Trispecific Antibody market?
Table of Contents
1 Market Overview of Bispecific and Trispecific Antibody
- 1.1 Bispecific and Trispecific Antibody Market Overview
- 1.1.1 Bispecific and Trispecific Antibody Product Scope
- 1.1.2 Bispecific and Trispecific Antibody Market Status and Outlook
- 1.2 Global Bispecific and Trispecific Antibody Market Size Overview by Region 2017 VS 2021 VS 2028
- 1.3 Global Bispecific and Trispecific Antibody Market Size by Region (2017-2028)
- 1.4 Global Bispecific and Trispecific Antibody Historic Market Size by Region (2017-2022)
- 1.5 Global Bispecific and Trispecific Antibody Market Size Forecast by Region (2023-2028)
- 1.6 Key Regions, Bispecific and Trispecific Antibody Market Size (2017-2028)
- 1.6.1 North America Bispecific and Trispecific Antibody Market Size (2017-2028)
- 1.6.2 Europe Bispecific and Trispecific Antibody Market Size (2017-2028)
- 1.6.3 Asia-Pacific Bispecific and Trispecific Antibody Market Size (2017-2028)
- 1.6.4 Latin America Bispecific and Trispecific Antibody Market Size (2017-2028)
- 1.6.5 Middle East & Africa Bispecific and Trispecific Antibody Market Size (2017-2028)
2 Bispecific and Trispecific Antibody Market Overview by Type
- 2.1 Global Bispecific and Trispecific Antibody Market Size by Type: 2017 VS 2021 VS 2028
- 2.2 Global Bispecific and Trispecific Antibody Historic Market Size by Type (2017-2022)
- 2.3 Global Bispecific and Trispecific Antibody Forecasted Market Size by Type (2023-2028)
- 2.4 Bispecific Antibody
- 2.5 Trispecific Antibody
3 Bispecific and Trispecific Antibody Market Overview by Application
- 3.1 Global Bispecific and Trispecific Antibody Market Size by Application: 2017 VS 2021 VS 2028
- 3.2 Global Bispecific and Trispecific Antibody Historic Market Size by Application (2017-2022)
- 3.3 Global Bispecific and Trispecific Antibody Forecasted Market Size by Application (2023-2028)
- 3.4 Cancer
- 3.5 Haemophilia
- 3.6 Others
4 Bispecific and Trispecific Antibody Competition Analysis by Players
- 4.1 Global Bispecific and Trispecific Antibody Market Size by Players (2017-2022)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bispecific and Trispecific Antibody as of 2021)
- 4.3 Date of Key Players Enter into Bispecific and Trispecific Antibody Market
- 4.4 Global Top Players Bispecific and Trispecific Antibody Headquarters and Area Served
- 4.5 Key Players Bispecific and Trispecific Antibody Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Bispecific and Trispecific Antibody Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 AbbVie
- 5.1.1 AbbVie Profile
- 5.1.2 AbbVie Main Business
- 5.1.3 AbbVie Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.1.4 AbbVie Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.1.5 AbbVie Recent Developments
- 5.2 Affimed
- 5.2.1 Affimed Profile
- 5.2.2 Affimed Main Business
- 5.2.3 Affimed Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.2.4 Affimed Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.2.5 Affimed Recent Developments
- 5.3 Biotheus
- 5.3.1 Biotheus Profile
- 5.3.2 Biotheus Main Business
- 5.3.3 Biotheus Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.3.4 Biotheus Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.3.5 Biontech Recent Developments
- 5.4 Biontech
- 5.4.1 Biontech Profile
- 5.4.2 Biontech Main Business
- 5.4.3 Biontech Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.4.4 Biontech Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.4.5 Biontech Recent Developments
- 5.5 Genmab
- 5.5.1 Genmab Profile
- 5.5.2 Genmab Main Business
- 5.5.3 Genmab Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.5.4 Genmab Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.5.5 Genmab Recent Developments
- 5.6 GT Biopharma
- 5.6.1 GT Biopharma Profile
- 5.6.2 GT Biopharma Main Business
- 5.6.3 GT Biopharma Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.6.4 GT Biopharma Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.6.5 GT Biopharma Recent Developments
- 5.7 Harpoon Therapeutics
- 5.7.1 Harpoon Therapeutics Profile
- 5.7.2 Harpoon Therapeutics Main Business
- 5.7.3 Harpoon Therapeutics Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.7.4 Harpoon Therapeutics Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.7.5 Harpoon Therapeutics Recent Developments
- 5.8 MacroGenics
- 5.8.1 MacroGenics Profile
- 5.8.2 MacroGenics Main Business
- 5.8.3 MacroGenics Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.8.4 MacroGenics Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.8.5 MacroGenics Recent Developments
- 5.9 Numab
- 5.9.1 Numab Profile
- 5.9.2 Numab Main Business
- 5.9.3 Numab Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.9.4 Numab Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.9.5 Numab Recent Developments
- 5.10 Sanofi
- 5.10.1 Sanofi Profile
- 5.10.2 Sanofi Main Business
- 5.10.3 Sanofi Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.10.4 Sanofi Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.10.5 Sanofi Recent Developments
- 5.11 Sichuan Baili Pharmaceuticals
- 5.11.1 Sichuan Baili Pharmaceuticals Profile
- 5.11.2 Sichuan Baili Pharmaceuticals Main Business
- 5.11.3 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.11.4 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.11.5 Sichuan Baili Pharmaceuticals Recent Developments
- 5.12 Roche
- 5.12.1 Roche Profile
- 5.12.2 Roche Main Business
- 5.12.3 Roche Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.12.4 Roche Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.12.5 Roche Recent Developments
- 5.13 Amgen
- 5.13.1 Amgen Profile
- 5.13.2 Amgen Main Business
- 5.13.3 Amgen Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.13.4 Amgen Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.13.5 Amgen Recent Developments
- 5.14 Pfizer
- 5.14.1 Pfizer Profile
- 5.14.2 Pfizer Main Business
- 5.14.3 Pfizer Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.14.4 Pfizer Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.14.5 Pfizer Recent Developments
- 5.15 Johnson & Johnson
- 5.15.1 Johnson & Johnson Profile
- 5.15.2 Johnson & Johnson Main Business
- 5.15.3 Johnson & Johnson Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.15.4 Johnson & Johnson Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.15.5 Johnson & Johnson Recent Developments
- 5.16 AstraZeneca
- 5.16.1 AstraZeneca Profile
- 5.16.2 AstraZeneca Main Business
- 5.16.3 AstraZeneca Bispecific and Trispecific Antibody Products, Services and Solutions
- 5.16.4 AstraZeneca Bispecific and Trispecific Antibody Revenue (US$ Million) & (2017-2022)
- 5.16.5 AstraZeneca Recent Developments
6 North America
- 6.1 North America Bispecific and Trispecific Antibody Market Size by Country (2017-2028)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Bispecific and Trispecific Antibody Market Size by Country (2017-2028)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
8 Asia-Pacific
- 8.1 Asia-Pacific Bispecific and Trispecific Antibody Market Size by Region (2017-2028)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 India
- 8.6 Australia
- 8.7 China Taiwan
- 8.8 Indonesia
9 Latin America
- 9.1 Latin America Bispecific and Trispecific Antibody Market Size by Country (2017-2028)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Argentina
10 Middle East & Africa
- 10.1 Middle East & Africa Bispecific and Trispecific Antibody Market Size by Country (2017-2028)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
11 Bispecific and Trispecific Antibody Market Dynamics
- 11.1 Bispecific and Trispecific Antibody Industry Trends
- 11.2 Bispecific and Trispecific Antibody Market Drivers
- 11.3 Bispecific and Trispecific Antibody Market Challenges
- 11.4 Bispecific and Trispecific Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Bispecific and Trispecific Antibody. Industry analysis & Market Report on Bispecific and Trispecific Antibody is a syndicated market report, published as Global Bispecific and Trispecific Antibody Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Bispecific and Trispecific Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
